These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 20689991
1. Pulmonary hemorrhage in type 3 Gaucher disease: a case report. Vellodi A, Ashworth M, Finnegan N, Wallis C. J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S329-31. PubMed ID: 20689991 [Abstract] [Full Text] [Related]
2. Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy. Tezuka Y, Fukuda M, Watanabe S, Nakano T, Okamoto K, Kuzume K, Yano Y, Eguchi M, Ishimae M, Ishii E, Miyazaki T. Blood Cells Mol Dis; 2018 Feb; 68():194-199. PubMed ID: 27866810 [Abstract] [Full Text] [Related]
3. [High dose of enzyme replacement therapy was successful for the pulmonary involvement in a case of type 2 Gaucher disease]. Arai N, Uematsu M, Abe Y, Fukuyo N, Wakusawa K, Kikuchi A, Sakamoto O, Ohura T, Tsuchiya S. No To Hattatsu; 2010 Jan; 42(1):45-9. PubMed ID: 23858612 [Abstract] [Full Text] [Related]
4. Late-onset Myoclonic Seizure in a 78-year-old Woman with Gaucher Disease. Yamaguchi-Takegami N, Takahashi A, Mitsui J, Sugiyama Y, Chikada A, Porto KJL, Takegami N, Sakuishi K, Ishiura H, Yamada K, Shimizu J, Tsuji S, Toda T. Intern Med; 2024 Mar 15; 63(6):861-865. PubMed ID: 37558486 [Abstract] [Full Text] [Related]
5. Small Bowel Mucosal Involvement and Mesenteric Mass Formation in a Young Female with Type 3 Gaucher Disease. A Case Report. Emanuel AJ, Holman N, Presnell SE, Welsh CT, Pai S, Sun S. J Gastrointestin Liver Dis; 2018 Dec 15; 27(4):459-463. PubMed ID: 30574629 [Abstract] [Full Text] [Related]
6. Platelet function defects in patients with Gaucher disease on long term ERT- implications for evaluation at bleeding challenges. Komninaka V, Repa K, Marinakis T, Pouliakis A, Koutsouri T, Tsokanas D, Flevary P, Voskaridou E, Politou M. Blood Cells Mol Dis; 2020 Feb 15; 80():102371. PubMed ID: 31670186 [No Abstract] [Full Text] [Related]
7. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia. Kim EA, Lim YT, Hah JO, Sohn YB, Kim YK, Choi JH, Kim SY, Jang KM, Ahn J, Lee JM. Int J Hematol; 2019 Mar 15; 109(3):361-365. PubMed ID: 30456712 [Abstract] [Full Text] [Related]
8. Gaucher disease with pulmonary involvement in a 6-year-old girl: report of resolution of radiographic abnormalities on increasing dose of imiglucerase. Lee SY, Mak AW, Huen KF, Lam ST, Chow CB. J Pediatr; 2001 Dec 15; 139(6):862-4. PubMed ID: 11743514 [Abstract] [Full Text] [Related]
9. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy. Sawicka-Gutaj N, Machaczka M, Kulińska-Niedziela I, Bernardczyk-Meller J, Gutaj P, Sowiński J, Ruchała M. Ups J Med Sci; 2016 Aug 15; 121(3):192-5. PubMed ID: 27064303 [Abstract] [Full Text] [Related]
10. Pulmonary manifestations in young Gaucher disease patients: Phenotype-genotype correlation and radiological findings. Gawad Tantawy AA, Moneam Adly AA, Madkour SS, Salah El-Din NY. Pediatr Pulmonol; 2020 Feb 15; 55(2):441-448. PubMed ID: 31774256 [Abstract] [Full Text] [Related]
11. IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report. Martinez-Redondo C, Ortuño FJ, Lozano ML, Jerez A, del Mar Osma M, Giraldo P, Vicente V. J Inherit Metab Dis; 2009 Dec 15; 32 Suppl 1():S265-7. PubMed ID: 19562501 [Abstract] [Full Text] [Related]
12. Pulmonary involvement in siblings with Gaucher disease type III. Djordjević M, Minić P, Sarajlija A, Djuricic SM, Djokić D, Marković O. Vojnosanit Pregl; 2011 Dec 15; 68(12):1071-4. PubMed ID: 22352271 [Abstract] [Full Text] [Related]
13. Enzyme Replacement Therapy in a Gaucher Family. Erdem N, Buran T, Berber I, Aydogdu I. J Natl Med Assoc; 2018 Aug 15; 110(4):330-333. PubMed ID: 30126557 [Abstract] [Full Text] [Related]
14. The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease. Charrow J, Dulisse B, Grabowski GA, Weinreb NJ. Clin Genet; 2007 Mar 15; 71(3):205-11. PubMed ID: 17309642 [Abstract] [Full Text] [Related]
15. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis. Mistry PK, Deegan P, Vellodi A, Cole JA, Yeh M, Weinreb NJ. Br J Haematol; 2009 Nov 15; 147(4):561-70. PubMed ID: 19732054 [Abstract] [Full Text] [Related]
16. Lung involvement and enzyme replacement therapy in Gaucher's disease. Goitein O, Elstein D, Abrahamov A, Hadas-Halpern I, Melzer E, Kerem E, Zimran A. QJM; 2001 Aug 15; 94(8):407-15. PubMed ID: 11493717 [Abstract] [Full Text] [Related]
17. Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey. Lau H, Belmatoug N, Deegan P, Goker-Alpan O, Schwartz IVD, Shankar SP, Panahloo Z, Zimran A. Blood Cells Mol Dis; 2018 Feb 15; 68():226-231. PubMed ID: 27839985 [Abstract] [Full Text] [Related]
18. Gaucher disease. Mignot C, Gelot A, De Villemeur TB. Handb Clin Neurol; 2013 Feb 15; 113():1709-15. PubMed ID: 23622393 [Abstract] [Full Text] [Related]
19. Enzyme therapy in Gaucher disease type 2: an autopsy case. Takahashi T, Yoshida Y, Sato W, Yano T, Shoji Y, Sawaishi Y, Sakuma I, Sashi T, Enomoto K, Ida H, Takada G. Tohoku J Exp Med; 1998 Oct 15; 186(2):143-9. PubMed ID: 10223617 [Abstract] [Full Text] [Related]
20. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. El-Beshlawy A, Tylki-Szymanska A, Vellodi A, Belmatoug N, Grabowski GA, Kolodny EH, Batista JL, Cox GF, Mistry PK. Mol Genet Metab; 2017 Oct 15; 120(1-2):47-56. PubMed ID: 28040394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]